Vapor retention assembly
    1.
    发明授权
    Vapor retention assembly 失效
    蒸汽保持组件

    公开(公告)号:US6116235A

    公开(公告)日:2000-09-12

    申请号:US884598

    申请日:1997-06-27

    IPC分类号: A61M16/00 A61M16/16 A61M15/00

    摘要: Methods and apparatus for the conservation of respiratory promoters following their pulmonary introduction are disclosed. In preferred embodiments the present invention provides methods and apparatus for reducing the loss of respiratory promoter, and particularly fluorochemcials, during medical procedures such as liquid ventilation. The disclosed methods comprise the use of vapor retention assemblies, which may be conventional heat and moisture exchangers, to passively retain the respiratory promoter and return it to the lungs in subsequent breaths. Novel vapor retention assemblies comprising fluorophilic exchange elements are also disclosed.

    摘要翻译: 公开了在肺部引入后保护呼吸促进剂的方法和装置。 在优选的实施方案中,本发明提供了用于在诸如液体通气的医疗过程期间减少呼吸促进剂,特别是氟化合物的损失的方法和装置。 所公开的方法包括使用可以是常规热和湿交换器的蒸汽保持组件来被动地保持呼吸促进剂并在随后的呼吸中将其返回到肺。 还公开了包含氟亲口交换元件的新型蒸气保留组件。

    Combined liquid ventilation and cardiopulmonary resuscitation method
    2.
    发明授权
    Combined liquid ventilation and cardiopulmonary resuscitation method 失效
    联合液体通气和心肺复苏方法

    公开(公告)号:US5927273A

    公开(公告)日:1999-07-27

    申请号:US813330

    申请日:1997-03-07

    摘要: A method and apparatus utilize liquid ventilation to increase the efficacy of cardiopulmonary resuscitation (CPR). The method involves replacing gas in the lungs with an oxygen and carbon dioxide carrying liquid to eliminate the decreased pumping efficiency of the heart seen during conventional or active compression-decompression (ACD) closed-chest CPR. A further advantage during ACD-CPR is the ability to perform liquid ventilation without a mechanical respirator. A further advantage is provided by supplying a continuous flow of liquid (or gaseous) ventilation medium throughout the entire chest compression/re-expansion cycle, dramatically accelerating both gas exchange and cooling or warming of the patient or animal subject.

    摘要翻译: 一种方法和装置利用液体通气来提高心肺复苏(CPR)的疗效。 该方法包括用携带氧气和二氧化碳的液体替换肺中的气体,以消除在常规或主动压缩减压(ACD)闭合胸腔CPR期间看到的心脏泵送效率降低。 ACD-CPR中的另一优势是无机械呼吸器进行液体通气的能力。 通过在整个胸部压缩/再膨胀循环中提供液体(或气体)通气介质的连续流动来提供进一步的优点,显着加速患者或动物受试者的气体交换和冷却或变暖。

    Extracorporeal lung assistance apparatus and process
    3.
    发明授权
    Extracorporeal lung assistance apparatus and process 失效
    体外肺辅助装置及过程

    公开(公告)号:US5277176A

    公开(公告)日:1994-01-11

    申请号:US905347

    申请日:1992-06-29

    IPC分类号: A61M1/16 A61M1/22 A61M15/00

    摘要: An extracorporeal lung assistance device having an oxygen-containing gas chamber positioned in such relationship to a gas exchange chamber that transfer of oxygen to blood and the withdrawal of carbon dioxide from blood disposed may be made. The gas exchange chamber has a blood flow channel extending through the gas exchanger defined by a microporous membrane forming a wall separating the blood flow channel from an oxygen, carbon dioxide exchange media. A second membrane supported in spaced-apart relationship from said first membrane. The space between the membranes is filled with the oxygen carbon dioxide exchange media.

    摘要翻译: 可以制造体外肺辅助装置,其具有与气体交换室相关联的含氧气体室,所述气体交换室将氧气输送到血液并且从所配置的血液中排出二氧化碳。 气体交换室具有延伸穿过由微孔膜限定的气体交换器的血流通道,所述微孔膜形成将血流通道与氧气二氧化碳交换介质分开的壁。 与所述第一膜以间隔开的关系支撑的第二膜。 膜之间的空间填充有氧二氧化碳交换介质。

    Methods and apparatus for reducing the loss of respiratory promoters
    6.
    发明授权
    Methods and apparatus for reducing the loss of respiratory promoters 失效
    减少呼吸启动子损失的方法和装置

    公开(公告)号:US5829428A

    公开(公告)日:1998-11-03

    申请号:US654551

    申请日:1996-05-29

    摘要: Methods and apparatus for the conservation of respiratory promoters following their pulmonary introduction are disclosed. In preferred embodiments the present invention provides methods and apparatus for reducing the loss of respiratory promoter, and particularly fluorochemcials, during medical procedures such as liquid ventilation. The disclosed methods comprise the use of vapor retention assemblies, which may be conventional heat and moisture exchangers, to passively retain the respiratory promoter and return it to the lungs in subsequent breaths. Novel vapor retention assemblies comprising fluorophilic exchange elements are also disclosed.

    摘要翻译: 公开了在肺部引入后保护呼吸促进剂的方法和装置。 在优选的实施方案中,本发明提供了用于在诸如液体通气的医疗过程期间减少呼吸促进剂,特别是氟化合物的损失的方法和装置。 所公开的方法包括使用可以是常规热和湿交换器的蒸汽保持组件来被动地保持呼吸促进剂并在随后的呼吸中将其返回到肺。 还公开了包含氟亲口交换元件的新型蒸气保留组件。

    Mixed-mode liquid ventilation gas and heat exchange
    9.
    发明授权
    Mixed-mode liquid ventilation gas and heat exchange 有权
    混合型液体通气和热交换

    公开(公告)号:US06694977B1

    公开(公告)日:2004-02-24

    申请号:US09543709

    申请日:2000-04-05

    IPC分类号: A61M1600

    摘要: A novel technique for ventilation and heat exchange is disclosed called Mixed-mode Liquid Ventilation (MMLV). This technique uses an endotracheal catheter to add and remove liquid from the lungs continuously and/or cyclically, and deliver gas at a rate independent of the delivery of liquid. This technique produces small-scale mixing of gas and liquid in the airways, allowing for efficient gas and heat exchange. Medical uses for the technique are disclosed. These uses include induction and reversal of hyperthermia, and hypothermia.

    摘要翻译: 公开了一种通气和热交换的新型技术,称为混合型液体通气(MMLV)。 该技术使用气管内导管连续地和/或循环地从肺中添加和去除液体,并且以与液体的输送无关的速率输送气体。 这种技术在气道中产生气体和液体的小规模混合,允许有效的气体和热交换。 公开了该技术的医疗用途。 这些用途包括诱导和逆转热疗,低体温。

    Inducing hypothermia and rewarming using a helium-oxygen mixture
    10.
    发明申请
    Inducing hypothermia and rewarming using a helium-oxygen mixture 有权
    使用氦 - 氧混合物诱导低体温和再温暖

    公开(公告)号:US20030131844A1

    公开(公告)日:2003-07-17

    申请号:US10310118

    申请日:2002-12-04

    IPC分类号: A61M016/00

    摘要: Devices and methods to heat and cool human beings, including inducing and maintaining hypothermia in human patients. Methods include inducing hypothermia to treat ischemic events, including heart attack and stroke, to limit damage caused by the ischemic event. Methods can include: using the lungs for heat exchange; using cooled gases for ventilation; using helium in the ventilation gas mixture, using medications to control reflex heat production; and injecting a perfluorocarbon mist into the gas stream to increase the cooling rate. The high thermal conductivity and diffusivity of helium results in greater inspired gas temperature equalization toward body temperature. Due to the latent heat of vaporization, addition of even small quantity of phase-change perfluorocarbon dramatically increases the heat carrying capacity of the respiratory gases. Hypothermia may be terminated by discontinuing the medications and warming the patient using a warmed helium-oxygen mixture.

    摘要翻译: 用于加热和冷却人类的装置和方法,包括诱导和维持人类患者体温过低。 方法包括诱导低温治疗缺血事件,包括心脏病发作和中风,以限制由缺血事件引起的损伤。 方法可以包括:使用肺进行热交换; 使用冷却气体进行通风; 在通风气体混合物中使用氦气,使用药物来控制反射热产生; 并将全氟化碳雾注入气流中以提高冷却速率。 氦气的高导热性和扩散性导致更大的启发气体温度均衡到体温。 由于蒸发潜热,加入少量相变全氟化碳会大大增加呼吸气体的承载能力。 可以通过中断药物并使用加热的氦 - 氧混合物使患者变暖来终止低体温。